What’s new at CHBRP? FEATURED Nov 26, 2024 Recruiting for a Principal Analyst! Join our dynamic team and contribute to impactful policy work in California. The Principal Analyst serves as the “CHBRP Lead” on many reports and analysis topics and is the principal policy analyst, facilitator, project manager, reviewer, and technical expert. The Lead also helps produce issue briefs, policy analyses, and legislative reports throughout the year. Apr 24, 2023 CHBRP has completed its analysis of AB 1060 (Ortega): Naloxone Hydrochloride Apr 24, 2023 CHBRP has completed its analysis of AB 1048 (Wicks): Dental Benefits and Rate Review Apr 24, 2023 CHBRP has completed its analysis of SB 427 (Portantino): Antiretroviral Drugs, Devices, and Products Apr 24, 2023 CHBRP has completed its analysis of SB 339 (Wiener): HIV Preexposure Prophylaxis and Postexposure Prophylaxis Apr 24, 2023 CHBRP has completed its analysis of AB 907 (Lowenthal): Coverage for PANDAS and PANS. Apr 24, 2023 CHBRP has completed its analysis of AB 1451 (Jackson): Behavioral Health Crisis Treatment Apr 24, 2023 CHBRP has completed its analysis of AB 874 (Weber): Out-of-pocket Expenses Apr 24, 2023 CHBRP has completed its analysis of SB 729 (Menjivar): Treatment for Infertility and Fertility Services Apr 18, 2023 CHBRP has completed its analysis of SB 1645 (Zbur): Cost Sharing Apr 18, 2023 CHBRP has completed its analysis of AB 1157 (Ortega): Rehabilitative and Habilitative Services: Durable Medical Equipment and Services Apr 18, 2023 CHBRP has completed its analysis of SB 694 (Eggman): Medi-Cal: Self-Measured Blood Pressure Devices and Services Apr 18, 2023 CHBRP has completed its analysis of AB 1288 (Reyes): Medication-Assisted Treatment Apr 18, 2023 CHBRP has completed its analysis of SB 621 (Connolly): Metabolic Disorders Apr 18, 2023 CHBRP has completed its analysis of AB 716 (Boerner Horvath): Emergency Ground Medical Transportation Apr 18, 2023 CHBRP has completed its analysis of SB 621 (Caballero): Biosimilar Drugs Mar 21, 2023 CHBRP has completed its analysis of SB 90 (Wiener): Insulin Affordability Mar 21, 2023 CHBRP has completed its analysis of SB 70 (Wiener): Prescription Drug Coverage Mar 21, 2023 CHBRP has completed its analysis of AB 85 (Weber): Social Determinants of Health: Screening and Outreach Feb 22, 2023 CHBRP has received a request to analyze SB 427 (Portantino): Cost Sharing and Utilization Management: Antiretroviral Drugs Feb 22, 2023 CHBRP has received a request to analyze AB 1060 (Ortega): Emergency Medical Services Feb 21, 2023 CHBRP has received a request to analyze AB 1288 (Reyes): Medication-assisted Treatment Pagination First page First Previous page Previous Page 1 Current page 2 Page 3 Next page Next Last page Last
